نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - mercaptopurine monohydrate 50mg; mercaptopurine monohydrate 50mg - tablet - 50 mg - active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid active: mercaptopurine monohydrate 50mg excipient: lactose monohydrate magnesium stearate maize starch stearic acid - puri-nethol is indicated for the treatment of acute leukaemia. it may be utilised in remission induction and is particularly indicated for maintenance therapy in: · acute lymphoblastic leukaemia; · acute myelogenous leukaemia.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - mercaptopurine monohydrate - tablet - 50 milligram(s) - purine analogues; mercaptopurine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

ltt pharma limited - mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - mercaptopurine 20 mg/ml - oral suspension - 20 mg/ml - active: mercaptopurine 20 mg/ml excipient: aspartame potassium sorbate purified water raspberry flavour - concentrated juice (nova) sodium ethyl hydroxybenzoate sodium hydroxide sodium methyl hydroxybenzoate xanthan gum - allmercap is indicated for the treatment of acute lymphoblastic leukaemia (all) in paediatric patients.

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - mercaptopurine 50 mg - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

primecrown 2010 limited - 6-mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

primecrown 2010 limited - 6-mercaptopurine - tablet - 50 milligram(s) - purine analogues; mercaptopurine

بلجيكا - الإنجليزية - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - mercaptopurine - tablet - 50 mg - mercaptopurine 50 mg - mercaptopurine

كندا - الإنجليزية - Health Canada

teva canada limited - mercaptopurine - tablet - 50mg - mercaptopurine 50mg - antineoplastic agents

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

fresenius kabi usa, llc - levothyroxine sodium anhydrous (unii: 054i36cpmn) (levothyroxine - unii:q51bo43mg4) - levothyroxine sodium anhydrous 100 ug in 5 ml - levothyroxine sodium for injection is indicated for the treatment of myxedema coma. important limitations of use: the relative bioavailability between levothyroxine sodium for injection and oral levothyroxine products has not been established.  caution should be used when switching patients from oral levothyroxine products to levothyroxine sodium for injection as accurate dosing conversion has not been studied. none. pregnancy category a – there are no reported cases of levothyroxine sodium for injection used to treat myxedema coma in patients who were pregnant or lactating.  studies in pregnant women treated with oral levothyroxine to maintain a euthyroid state have not shown an increased risk of fetal abnormalities.  therefore, pregnant patients who develop myxedema should be treated with levothyroxine sodium for injection as the risk of nontreatment is associated with a high probability of significant morbidity or mortality to the maternal patient and the fetus. patients in labor who develop myxedema have